Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|June 17, 2026
Cardiovascular Outcomes in a SELECT-Like Obesity Cohort: Real-World Insights From the Swedish AROS DatabaseViveca Ritsinger, Josefine Fagerström, Håkan Nero, et al.Family Practice|July 5, 2013
Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011Per Wändell, Axel C Carlsson, Björn Wettermark, et al.Annals of Clinical Biochemistry|November 17, 2025
NT-proBNP and its correlation to left ventricular ejection fraction and heart failure - The DEMONSTRATE databaseMorgan Lundgren, Peter Ridefelt, Maria K Svensson, et al.BMJ Open|November 18, 2017
Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based studyThomas Cars, Irene Eriksson, Anna Granath, et al.European Journal of Clinical Pharmacology|November 13, 2017
Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort studyIrene Eriksson, Thomas Cars, Fredrik Piehl, et al.Diabetes, Obesity & Metabolism|May 14, 2026
Underdiagnosed and Undertreated: Obesity and Its Cardiometabolic Burden in Swedish Clinical Practice-Insights From the AROS DatabaseViveca Ritsinger, Magnus Sundbom, Jonatan Dereke, et al.Journal of the American Heart Association|April 9, 2024
Usefulness of Heart Failure Categories Based on Left Ventricular Ejection FractionMalin Christersson, Stefan Gustafsson, Erik Lampa, et al.BMC Nephrology|April 28, 2025
Potassium binders in clinical practice: understanding potassium binder use in contemporary Swedish healthcare-the DEMONSTRATE databaseHans Furuland, Anders Olof Larsson, Per Bjellerup, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Prediction of fracture risk in men: a cohort studyLiisa Byberg, Rolf Gedeborg, Thomas Cars, et al.Journal of Internal Medicine|March 26, 2026
Potassium binders and continuation of renin-angiotensin system inhibitors/mineralocorticoid receptor antagonist in chronic kidney disease and heart failure (the DEMONSTRATE database)Hans Furuland, Anders Olof Larsson, Milica Uhde, et al.Pageof 4